Capricor Therapeutics Inc (CAPR)
18.14
-0.44
(-2.37%)
USD |
NASDAQ |
Nov 05, 10:34
Capricor Therapeutics Shareholders Equity (Quarterly): 11.50M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 11.50M |
March 31, 2024 | 18.43M |
December 31, 2023 | 22.60M |
September 30, 2023 | -1.788M |
June 30, 2023 | 2.731M |
March 31, 2023 | 6.206M |
December 31, 2022 | 11.79M |
September 30, 2022 | 15.43M |
June 30, 2022 | 18.73M |
March 31, 2022 | 24.64M |
December 31, 2021 | 31.37M |
September 30, 2021 | 36.74M |
June 30, 2021 | 33.38M |
March 31, 2021 | 36.38M |
December 31, 2020 | 28.20M |
September 30, 2020 | 30.41M |
June 30, 2020 | 31.65M |
March 31, 2020 | 9.593M |
December 31, 2019 | 6.839M |
September 30, 2019 | 3.570M |
June 30, 2019 | 2.364M |
March 31, 2019 | 3.740M |
December 31, 2018 | 4.616M |
September 30, 2018 | 6.980M |
June 30, 2018 | 9.631M |
Date | Value |
---|---|
March 31, 2018 | 10.53M |
December 31, 2017 | 11.23M |
September 30, 2017 | -4.271M |
June 30, 2017 | -6.586M |
March 31, 2017 | -7.192M |
December 31, 2016 | -4.003M |
September 30, 2016 | 0.0491M |
June 30, 2016 | -5.116M |
March 31, 2016 | -1.083M |
December 31, 2015 | -1.032M |
September 30, 2015 | 1.926M |
June 30, 2015 | 4.555M |
March 31, 2015 | 7.324M |
December 31, 2014 | -6.249M |
September 30, 2014 | -4.472M |
June 30, 2014 | -3.085M |
March 31, 2014 | -1.659M |
December 31, 2013 | -0.5349M |
September 30, 2013 | -1.568M |
June 30, 2013 | -1.233M |
March 31, 2013 | -0.6427M |
December 31, 2012 | 4.894M |
September 30, 2012 | 0.0272M |
June 30, 2012 | 0.5423M |
March 31, 2012 | 0.2307M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-1.788M
Minimum
Sep 2023
36.74M
Maximum
Sep 2021
19.73M
Average
18.73M
Median
Jun 2022
Shareholders Equity (Quarterly) Benchmarks
Abbott Laboratories | 39.80B |
ResMed Inc | 5.195B |
enVVeno Medical Corp | 47.37M |
Regenxbio Inc | 348.27M |
AIM ImmunoTech Inc | 6.102M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 38.28M |
Total Liabilities (Quarterly) | 26.78M |
Current Ratio | 1.372 |